Rate My Professor Santosh Rudrawar

His research specializes in medicinal and organic chemistry, focusing on drug discovery and development for infectious diseases, neurodegeneration, and glycomics-related targets. Key contributions include the synthesis of novel sialic acid derivatives that lock open the 150-loop of an influenza A virus group-1 sialidase (Nature Communications, 2010, 130 citations), bisubstrate uridine-mimetic-peptide conjugates as inhibitors of human O-GlcNAc transferase (2020), and simplified novel muraymycin analogues using a serine protease (ChemMedChem, 2020). Highly cited works encompass magnesium perchlorate as an efficient catalyst for imine and phenylhydrazone synthesis (2004, 267 citations), 'on water' organic synthesis of benzothiazoles (2007, 227 citations), and liposomal doxorubicin as a targeted delivery platform (2021, 158 citations). With over 1,500 citations across 58 publications, his research demonstrates substantial impact in synthetic organic chemistry and pharmaceutical sciences. Rudrawar leads the integration of clinically relevant medicinal chemistry content in Bachelor of Pharmacy programs accredited by the Australian Pharmacy Council and supervises higher degree research students. He has secured significant funding, including a Griffith University Discovery Project grant valued at $767,243 in 2024 for 'Breaking the Cycle.' His professional activities include contributions to HDR career development sessions.